An observational study to evaluate haemostasis action of VELSEAL-T in haemophilia patients with external bleeding

Dr Anupam Dutta0 个研究点目标入组 48 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Patients above 18 years of age with haemophilia disorders who require haemostasis control.
•2. Patients who can provide informed consent form in writing and medically in a position to undergo consent for data collection.
•3. Subjects willing and able to comply with the requirements of the study protocol, including the predefined follow-up evaluations.

•1. Subjects with medical emergency, where treatment is the priority than the informed consent process and his/her representative deny to participant in the study.
•2. Subjects who cannot provide the informed consent such as unconscious subjects.
•3. The subjects who have been treated with other higher treatment for Haemorrhage control such as Tourniquets for more than 2 hours, Blood or platelet-rich-plasma transfusion etc.
•4. Subjects with known possible loss of plasma or blood from other areas than wound such as lacerations, Uterine bleeding, Gastro-intestinal bleeding etc.
•5. Subjects with an active infection at the injury site.

发起方

Dr Anupam Dutta